Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer

Gynecologic Oncology

Volumn 86, Issue 2, 2002, Pages 144-149

  Butler, David ^a   Collins, Claire ^b   Mabruk, Mohamed ^a   Leader, Mary B ^a   Kay, Elaine W ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cervical cancer; FHIT gene; Fhit protein; HPV; LOH

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE DELETION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

EID: 0036354547     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6712     Document Type: Article

References (25)

1. Natural history of cervicovaginal papillomavirus infection in young women
2. Human papillomavirus testing and the management of women with mildly abnormal cervical smears: An observational study
3. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features
4. Comparison of chromosome 3p deletions between cervical precancers synchronous with and without invasive cancer
5. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: Direct evidence for the coincidence of viral integration sites and fragile sites
6. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix
7. PCR-RFLP studies on chromosome 3p in formaldehyde-fixed paraffin-embedded cervical cancer tissues
8. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma
9. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: Association with human papilloma virus type
10. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix
11. Tumor suppressor genes: Does FHIT fit
12. Immunohistochemical evaluation of Fhit protein expression in oral squamous cell carcinomas
13. Abnormalities of the FHIT gene in human oral carcinogenesis
14. Absence or reduction of Fhit expression in most clear cell renal carcinomas
15. Loss of FHIT function in lung cancer and preinvasive bronchial lesions
16. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus
17. Clinicopathological significance of Fhit protein expression in stage 1 non-small cell lung carcinoma
18. Loss of Fhit expression in cervical carcinoma cell lines and primary tumors
19. Fragile histidine triad transcription abnormalities and human papilloma virus E6-E7 mRNA expression in the development of cervical carcinoma
20. A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix
21. Abnormal Fhit expression in malignant and premalignant lesions of the cervix
22. FHIT alterations in cancerous and non-cancerous cervical epithelium
23. Loss of Fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease
24. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early stage cervical cancer: A possible role for type 18
25. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers